is there a lawsuit against tirzepatide Eli Lilly sues Mochi Health and others for 'deceptive' marketing Novo Nordisk, maker of the

Resmetirom improves MASH by activating thyroid hormone receptor-beta (THR-), which promotes lipophagy and hepatic fatty acid -oxidation, thereby reducing liver fat (Harrison et al

Family members and carers play a vital role in monitoring for subtle changes that patients themselves may not recognise, particularly in the early weeks of treatment

Patients harmed by contaminated, mislabeled, or improperly dosed compounded versions may file Zepbound claims directly against the compounding pharmacy

Asiatic acid: a review on its polypharmacological properties and therapeutic potential against various Maladies

Ethics declarations Competing interests A.Y.T